ObvioHealth was asked to conduct an observational study of infant crying and fussing.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
VaxArt needed solutions for evaluating the safety and immunogenicity of its orally administered norovirus vaccine. Of particular importance was incorporating a way to quickly detect severe reactogenicity symptoms during the first week following vaccine administration.
A government agency is aiming to identify digital biomarkers of depressive and anxious feelings. The agency needed to capture both objective and subjective data for analysis.